PUBLICATIONS

  1. Korkmaz A, Reiter RJ, Tan DX, Manchester LC, Fuentes-Broto L, Hardman E, Rosales-Corral S, Wenbo Q, Topal T. “A walnut-enriched diet reduces the growth of LNCaP human prostate cancer xenografts in nude mice.” 12th Internetional Congress on targeted anticancer therapies, 2014 Washington-USA
  2. Reiter RJ, Tan DX, Korkmaz A, Rosales-Corral SA. “Melatonin and stable circadian rhythms optimize maternal, placental and fetal physiology.” Hum Reprod Update.;20(2):293-307, 2014
  3. Tan DX, Korkmaz A, Reiter RJ, Manchester LC. “Ebola virus disease: potential use of melatonin as a treatment.” J Pineal Res. ;57(4):381-4, 2014
  4. Reiter RJ, Tan DX, Manchester LC, Korkmaz A, Fuentes-Broto L, Hardman WE, Rosales-Corral SA, Qi W. “A walnut-enriched diet reduces the growth of LNCaP human prostate cancer xenografts in nude mice.” Cancer Invest.;31(6):365-73, 2013
  5. Reiter RJ, Korkmaz A, Ma S, Rosales-Corral S, Tan DX. “Melatonin protection from chronic, low-level ionizing radiation.” Mutat Res;751:7–14, 2012.
  6. Tan DX, Hardeland R, Manchester LC, Korkmaz A, Ma S, Rosales-Corral S, Reiter RJ. “Functional roles of melatonin in plants, and perspectives in nutritional and agricultural science.” J Exp Bot.;63(2):577-97, 2012
  7. Korkmaz A, Ma S, Topal T, Rosales-Corral S, Tan DX, Reiter RJ. “Glucose: a vital toxin and potential utility of melatonin in protecting against the diabetic state.” Mol Cell Endocrinol.;349(2):128-37, 2012
  8. Rosales-Corral SA, Acuña-Castroviejo D, Coto-Montes A, Boga JA, Manchester LC, Fuentes-Broto L, Korkmaz A, Ma S, Tan DX, Reiter RJ. “Alzheimer’s disease: pathological mechanisms and the beneficial role of melatonin.” J Pineal Res.;52(2):167-202, 2012
  9. Korkmaz A, Rosales-Corral S, Reiter RJ. “Gene regulation by melatonin linked to epigenetic phenomena.” Gene.;503(1):1-11, 2012
  10. Reiter RJ, Tan DX, Korkmaz A, Ma S. “Obesity and metabolic syndrome: association with chronodisruption, sleep deprivation, and melatonin suppression.” Ann Med.;44(6):564-77, 2012
  11. Korkmaz A, Reiter RJ, Tan DX, Manchester LC. “Melatonin; from pineal gland to healthy foods” Spatula DD.; 1(1):33-36, 2011
  12. Reiter RJ, Tan DX, Sanchez-Barcelo E, Mediavilla MD, Gitto E, Korkmaz A. “Circadian mechanisms in the regulation of melatonin synthesis: disruption with light at night and the pathophysiological consequences” Journal of Experimental and Integrative Medicine; 1(1):13-22, 2011
  13. Korkmaz A, Manchester LC, Topal T, Ma S, Tan DX, Reiter RJ. “Epigenetic mechanisms in human physiology and diseases” Journal of experimental and integrative medicine 1(3):139-147, 2011
  14. Reiter RJ, Tan DX, Korkmaz A, Fuentes-Broto L. “Drug-mediated ototoxicity and tinnitus: alleviation with melatonin.” J Physiol Pharmacol. 62(2):151-7, 2011
  15. Reiter RJ, Tan DX, Korkmaz A, Manchester LC. “The disaster in Japan: utility of melatonin in providing protection against ionizing radiation.” J Pineal Res.;50(4):357-8, 2011
  16. Korkmaz A, Reiter RJ. “Gece ışığa maruz kalma, sirkadiyen melatonin ritmi ve metabolik bozulma”, Turkiye Klinikleri J Cardiovasc Sci.;21(3):434-49, 2009.
  17. Korkmaz A, Tamura H, Manchester LC, Ogden GB, Tan DX, Reiter RJ. “Combination of melatonin and a peroxisome proliferator-activated receptor-gamma agonist induces apoptosis in a breast cancer cell line”, Journal of Pineal Research;46(1):115-116, 2009.
  18. Ulas U, Korkmaz A, Karadas O, Odabasi Z, Reiter RJ. “Sunrise-related headache: case report”, Cephalalgia. 2009 May 15.
  19. Öter Ş, Sadır S, Uysal B, Özler M, Şimşek K, Ay H, Yaman H, Oğur R, Reiter RJ, Topal T, Korkmaz A. “Hyperbaric oxygen stimulates the transcription rate of the antioxidant enzyme cupper/zinc-superoxide dismutase in rat brain cortex tissue”, Journal of Cerebral Blood Flow & Metabolism; 29(Suppl1):S462-463, 2009.
  20. Korkmaz A, Reiter RJ, Topal T, Manchester LC, Öter Ş, Tan DX. “Melatonin: an established antioxidant worthy of use in clinical trials”, Molecular Medicine; 15(1-2):43-50, 2009.
  21. Paredes SD, Korkmaz A, Manchester LC, Tan DX, Reiter RJ. “Phytomelatonin: a review”, J Exp Bot; 60(1):57-69, 2009.
  22. Reiter RJ, Tan DX, Korkmaz A. “The circadian melatonin rhythm and its modulation: possible impact on hypertension”, J Hypertens; 27 Suppl 6:S17-20, 2009.
  23. Tamura H, Nakamura Y, Korkmaz A, Manchester LC, Tan DX, Sugino N, Reiter RJ.  “Melatonin and the ovary: physiological and pathophysiological implications”, Fertil Steril; 92(1):328-43, 2009.
  24. Tan DX, Hardeland R, Manchester LC, Paredes SD, Korkmaz A, Sainz RM, Mayo JC, Fuentes-Broto L, Reiter RJ. “The changing biological roles of melatonin during evolution: from an antioxidant to signals of darkness, sexual selection and fitness”, Biol Rev Camb Philos Soc. 2009.
  25. Korkmaz A, Sanchez-Barcelo EJ, Tan DX, Reiter RJ. “Role of melatonin in the epigenetic regulation of breast cancer”, Breast Cancer Res Treat;115(1):13-27, 2009.
  26. Korkmaz A, Topal T, Tan DX, Reiter RJ. “Role of melatonin in metabolic regulation”, Rev Endocr Metab Disord; 10(4):261-70, 2009.
  27. Korkmaz A, Tan DX, Reiter RJ. “Acute and delayed sulfur mustard toxicity; novel mechanisms and future studies”, Interdisciplinary Toxicology; 1(1):22-26, 2008.
  28. Reiter RJ, Paredes SD, Korkmaz A, Jou MJ, Tan DX. “Melatonin combats molecular terrorism at the mitochondrial level”, Interdisciplinary Toxicology; 1(2):137-149, 2008.
  29. Tekbas OF, Ogur R, Korkmaz A, Kilic A, Reiter RJ. Melatonin as an antibiotic: new insights into the actions of this ubiquitous molecule. J Pineal Res;44(2):222-6, 2008.
  30. Reiter RJ, Paredes SD, Korkmaz A, Manchester LC, Tan DX. “Melatonin in relation to the “strong” and “weak” versions of the free radical theory of aging”, Adv Med Sci. 53(2):119-29, 2008.
  31. Korkmaz A, Reiter RJ. ” Epigenetic regulation: a new research area for melatonin?”, J Pineal Res; 44(1):41-4, 2008.
  32. Korkmaz A, Kunak ZI, Paredes SD, Yaren H, Tan DX, Reiter RJ. “The use of melatonin to combat mustard toxicity”, REVIEW. Neuro Endocrinol Lett;29(5):614-9, 2008.
  33. Reiter RJ, Korkmaz A. “Clinical aspects of melatonin”, Saudi Med J; 29(11):1537-47, 2008.
  34. Reiter RJ, Korkmaz A, Paredes SD, Manchester LC, Tan DX. “Melatonin reduces oxidative/nitrosative stress due to drugs, toxins, metals, and herbicides”, Neuro Endocrinol Lett; 29(5):609-13, 2008.
  35. Göçgeldi E, Uysal B, Korkmaz A, Oğur R, Reiter RJ, Kurt B, Öter Ş, Topal T, Hasde M. “Establishing the use of melatonin as an adjuvant therapeutic against paraquat-induced lung toxicity in rats”, Experimental Biology and Medicine; 233(9):1133-1141, 2008.
  36. Reiter RJ, Tan DX, Jou MJ, Korkmaz A, Manchester LC, Paredes SD. “Biogenic amines in the reduction of oxidative stress: melatonin and its metabolites”, Neuro Endocrinol Lett. 2008; 29(4):391-8, 2008.
  37. Korkmaz A, Topal T, Öter Ş, Tan DX, Reiter RJ. “Hyperglycemia-related pathophysiologic mechanisms and potential beneficial actions of melatonin”, Mini Reviews in Medicinal Chemistry; 8(11):1144-1153, 2008
  38. Mollaoğlu H, Topal T, Özler M, Uysal B, Reiter RJ, Korkmaz A, Öter Ş. “Antioxidant effects of melatonin in rats during chronic exposure to hyperbaric oxygen”, Journal of Pineal Research; 42(1):50-54, 2007.
  39. Uçar M, Korkmaz A, Reiter RJ, Yaren H, Öter Ş, Kurt B, Topal T. “Melatonin alleviates lung damage induced by the chemical warfare agent nitrogen mustard”, Toxicology Letters; 10;173(2):124-131, 2007.
  40. Reiter RJ, Tan DX, Korkmaz A, Erren TC, Piekarski C, Tamura H, Manchester LC. “Light at night, chronodisruption, melatonin suppression, and cancer risk: a review”, Crit Rev Oncog. Dec;13(4):303-28, 2007.
  41. Topal T, Öter Ş, Korkmaz A, Sadır S, Metinyurt G, Korkmazhan ET, Serdar MA, Bilgiç H, Reiter RJ. “Exogenously administered and endogenously produced melatonin reduce hyperbaric oxygen-induced oxidative stress in rat lung”, Life Sciences; 75(4):461-467, 2004.